Pacific Biosciences Of California | PACB - Assets


Pacific Biosciences Of California reported $784.08M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Agilent USD 12.81B 86M Dec/2025
Bruker USD 6.24B 193.5M Dec/2025
Danaher USD 83.46B 3.57B Dec/2025
General Electric Aerospace USD 130.17B 1.93B Dec/2025
Illumina USD 6.64B 467M Dec/2025
Myriad Genetics USD 706.6M 21.5M Dec/2025
Pacific Biosciences Of California USD 784.08M 19.08M Dec/2025
Quidel USD 5.77B 94.2M Dec/2025
Revvity USD 12.17B 29.46M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Standard Biotools USD 567.75M 28.12M Dec/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Waters USD 5.08B 221.41M Dec/2025